ArticleCancer management and research2018

Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways.

Lixia Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.